Golden Throat Holdings Group Company Limited (HKG:6896)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
3.060
-0.010 (-0.33%)
At close: Mar 10, 2026
-4.08%
Market Cap 2.27B
Revenue (ttm) 1.07B
Net Income (ttm) 293.79M
Shares Out 739.30M
EPS (ttm) 0.40
PE Ratio 7.73
Forward PE n/a
Dividend 0.50 (16.29%)
Ex-Dividend Date Jun 16, 2025
Volume 200,500
Average Volume 580,350
Open 3.060
Previous Close 3.070
Day's Range 3.030 - 3.090
52-Week Range 3.000 - 5.650
Beta 0.08
RSI 38.82
Earnings Date Mar 27, 2026

About HKG:6896

Golden Throat Holdings Group Company Limited, an investment holding company, manufactures and sells pharmaceutical, healthcare food, and other products in the People’s Republic of China and internationally. The company offers Golden Throat Lozenges, an over-the-counter medicine to relieve symptoms of sore and dry throat, and hoarse voice caused by acute pharyngitis. It also provides Golden Throat Lozenge series products, which include Dule Lozenges; sugar-free Dule Lozenges; and other sugar free flavours, such as orange, fructus momordicae, chr... [Read more]

Sector Healthcare
Founded 1956
Employees 842
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6896
Full Company Profile

Financial Performance

In 2024, HKG:6896's revenue was 1.19 billion, an increase of 23.26% compared to the previous year's 961.38 million. Earnings were 318.63 million, an increase of 27.37%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.